Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Myelodysplastic Syndrome
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Pretransplant
100%
Disease Burden
100%
95% Confidence Interval
100%
Myeloablative Conditioning
53%
Disease-free Survival
46%
Nonmyeloablative
30%
Complete Remission
30%
Marrow
23%
Unrelated Cord Blood
23%
Treatment-related Mortality
23%
Prior Treatment
15%
Peripheral Blood Stem Cells
15%
Overall Survival
15%
Myeloablative
15%
Unrelated Donor
15%
Refractory Cytopenia with multilineage Dysplasia
15%
Chronic Graft-versus-host Disease (cGVHD)
15%
University of Minnesota
7%
Transplantation
7%
Bone Marrow
7%
Hematopoietic Stem Cell Transplantation
7%
Transplant Outcomes
7%
Chronic Myeloid Leukemia
7%
Living Donor
7%
Relapse Prevention
7%
Relapse Risk
7%
Total Body Irradiation
7%
Disease Status
7%
Conditioning Regimen
7%
Relapse Rate
7%
Cumulative Incidence
7%
Donor Source
7%
Graft Source
7%
Transplant-related Mortality
7%
Conditioning Intensity
7%
Curative Treatment
7%
Neutrophil Engraftment
7%
Disease Syndrome
7%
Relapsed Disease
7%
Age 50
7%
Not Otherwise Specified
7%
Annualized Relapse Rate
7%
Blast Count
7%
WHO Criteria
7%
Ring Sideroblasts
7%
Refractory Anemia
7%
Refractory Anemia with Excess Blasts
7%
Impact Rate
7%
Myelodysplastic-myeloproliferative Diseases
7%
RAEB-1
7%
Patient Median
7%
Medicine and Dentistry
Allogeneic Stem Cell Transplantation
100%
Myelodysplastic Syndrome
100%
Disease Burden
100%
Disease Free Survival
100%
Myeloablative Conditioning
83%
Cord Blood
50%
Refractory Anemia with Excess of Blasts
50%
Peripheral Blood Stem Cell
33%
Cumulative Incidence
33%
Overall Survival
33%
Nonmyeloablative Conditioning
33%
Engraftment
16%
Whole Body Radiation
16%
Acute Graft Versus Host Disease
16%
Hematopoietic Stem Cell Transplantation
16%
Recurrence Risk
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Bone Marrow Stem Cell
16%
Chronic Myelomonocytic Leukemia
16%
Refractory Anemia
16%
Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts
16%
Refractory Cytopenia with Multilineage Dysplasia
16%
Mixed Myelodysplastic Myeloproliferative Disease
16%
Graft Versus Host Reaction
16%
Diseases
16%
Neutrophil
16%